Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

LONDON BRIEFING: Taylor Wimpey expects house completions to drop

2nd Mar 2023 07:57

(Alliance News) - Stocks were called to open flat in London, with market attention on a raft of corporate earnings, as well as a eurozone inflation reading at 1000 GMT. Read More

US FDA panel supports GSK vaccine ahead of approval decision

2nd Mar 2023 07:00

(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration's advisory committee voted to support its respiratory syncytial virus vaccine candidate for older adults. Read More

LONDON MARKET EARLY CALL: Stocks called higher; pound below USD1.20

2nd Mar 2023 06:56

(Alliance News) - Stocks in London are set to open higher on Thursday, ahead of a eurozone inflation reading. Read More

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

27th Feb 2023 09:26

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday: Read More

LONDON MARKET CLOSE: FTSE 100 struggles, but European peers rise

23rd Feb 2023 17:00

(Alliance News) - Stock prices in London closed mixed on Thursday, with blue-chips ending in the red on renewed concerns of higher rates in the US, as well as a host of stocks going ex-dividend. Read More

GSK, Pfizer venture says HIV injectable therapy preferred in trial

23rd Feb 2023 09:02

(Alliance News) - GSK PLC on Thursday said that ViiV Healthcare has found that its injectable Cabenuva is as effective as the daily oral Biktarvy in treating HIV-1. Read More

GSK, Pfizer joint venture gets EU marketing approval for HIV treatment

22nd Feb 2023 13:13

(Alliance News) - ViiV Healthcare on Wednesday said it received marketing authorisation from the European Commission for Triumeq PD, a treament for children living with HIV Read More

UK dividends calendar - next 7 days

16th Feb 2023 15:47

Read More

GSK hails positive phase III trial results for RSV vaccine candidate

16th Feb 2023 09:04

(Alliance News) - GSK PLC on Thursday said a New England Journal of Medicine publication announced positive phase III trial results for its respiratory syncytial virus vaccine candidate for older adults. Read More

LONDON BROKER RATINGS: Shell, Glencore, Smurfit and abrdn ratings cut

10th Feb 2023 09:52

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning: Read More

TOP NEWS: GSK's Jemperli wins approval and trial evaluation in US

10th Feb 2023 08:04

(Alliance News) - GSK PLC on Friday said its drug Jemperli won a regular approval for a form of endometrial cancer and is set to be evaluated for a form of advanced rectal cancer in the US. Read More

GSK gets FDA approval for drug to treat anaemia in adults on dialysis

2nd Feb 2023 09:26

(Alliance News) - GSK PLC on Thursday said its Jesduvroq drug has been approved by the US Food & Drug Administration for anaemia of chronic kidney disease in adults on dialysis. Read More

LONDON BROKER RATINGS: Goldman Sachs cuts Standard Chartered

2nd Feb 2023 09:19

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

LONDON MARKET OPEN: GSK profit up; Vodafone growth slows; US Fed ahead

1st Feb 2023 09:13

(Alliance News) - Stock prices in London opened higher on Wednesday, as investors expect to see the US central bank continue to slow the pace of its interest rate hikes. Read More

TOP NEWS: GSK profit grows as aims for first-ever approved RSV vaccine

1st Feb 2023 09:09

(Alliance News) - GSK PLC on Wednesday reported a growth in profit and revenue for 2022 as it looks towards a possible spate of drug approvals for 2023. Read More

CORRECT: Stocks open higher ahead of US Fed rate decision

1st Feb 2023 08:03

(Correcting 2021 comparison figure for GSK revenue.) Read More

LONDON BRIEFING: Stocks called higher ahead of US Fed rate decision

1st Feb 2023 07:55

(Alliance News) - Stocks in London were set to open higher on Wednesday, following positive leads from Wall Street and Asia, as investors anxiously look ahead to a trio of interest rate decisions this week. Read More

Haleon appoints Pfizer Chief Financial Officer David Denton to board

31st Jan 2023 12:54

(Alliance News) - Haleon PLC on Tuesday said it will add Pfizer Inc Chief Financial Officer David Denton to its board of directors from March 1. Read More

UK earnings, trading statements calendar - next 7 days

25th Jan 2023 15:45

Read More

IN BRIEF: IP Group appoints GSK's Anita Kidgell as non-executive

18th Jan 2023 11:10

IP Group PLC - Oxford, England-based intellectual property commercialisation company - Appoints Anita Kidgell as an independent non-executive director, effective from Wednesday. Kidgell is currently head of Corporate Strategy at GSK PLC. GSK is a London-based multinational pharmaceutical and biotechnology company. Says Kidgell will bring a combination of a scientific background together with strategic and communication experience in a listed company. Read More

FTSE 100 Latest
Value8,275.66
Change0.00